From: The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease
CD patients
Control subjects (n = 482)
Total (n = 333)
Pediatric-onset CD (n = 137)
Adult-onset CD (n = 196)
Sex, M/F
148/185
71/66
77/119
311/171
Age, median (interquartile range)
21 (14-30)1
14 (12-16)1
28 (23-35)1
12 (7-34)2